US20100292656A1 - Drug delivery device for drug suspensions - Google Patents

Drug delivery device for drug suspensions Download PDF

Info

Publication number
US20100292656A1
US20100292656A1 US12/863,474 US86347409A US2010292656A1 US 20100292656 A1 US20100292656 A1 US 20100292656A1 US 86347409 A US86347409 A US 86347409A US 2010292656 A1 US2010292656 A1 US 2010292656A1
Authority
US
United States
Prior art keywords
proximal end
flow control
control surface
needle
distal end
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/863,474
Other languages
English (en)
Inventor
Roger Groskopf
Behzad D. Mottahed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Becton Dickinson and Co
Original Assignee
Becton Dickinson and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson and Co filed Critical Becton Dickinson and Co
Priority to US12/863,474 priority Critical patent/US20100292656A1/en
Assigned to BECTON, DICKINSON AND COMPANY reassignment BECTON, DICKINSON AND COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GROSKOPF, ROGER, MOTTAHED, BEHZAD D.
Publication of US20100292656A1 publication Critical patent/US20100292656A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3293—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle hub
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M5/2066—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M5/2448—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/24—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic
    • A61M5/2455—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened
    • A61M5/2466—Ampoule syringes, i.e. syringes with needle for use in combination with replaceable ampoules or carpules, e.g. automatic with sealing means to be broken or opened by piercing without internal pressure increase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M5/3134—Syringe barrels characterised by constructional features of the distal end, i.e. end closest to the tip of the needle cannula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/34—Constructions for connecting the needle, e.g. to syringe nozzle or needle hub
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M2005/31516—Piston or piston-rod constructions, e.g. connection of piston with piston-rod reducing dead-space in the syringe barrel after delivery

Definitions

  • This invention relates to drug delivery devices for addressing the problems associated with solids coming out of drug suspension.
  • Certain drugs or medicaments are preferably provided in powder or dry form (e.g., lyophilized form). Such powdered drugs are commonly suspended in a liquid diluent or carrier to allow delivery to an individual through injection. The powder drug is combined with the diluent prior to injection and administered in solution form.
  • Drug delivery systems typically have a reservoir with a large diameter, for example a syringe barrel or drug cartridge, for containing the drug solution.
  • Prior art devices have been developed that provide a diluent and dry substance in separate chambers of a common container or reservoir, with the container being configured to permit the flow of the diluent to the dry substance to cause mixing thereof in forming a solution.
  • U.S. Pat. No. 4,874,381 to Vetter is directed to an injector configured for mixing
  • U.S. Pat. No. 4,968,299 to Ahlstrand et al. is directed to a drug cartridge for mixing.
  • Drug delivery systems typically have a reservoir with a large diameter, for example a syringe barrel or drug cartridge, as compared to the fluid path used for delivery of the drug.
  • the fluid path at delivery is reduced in diameter by travel of the solution through a hub or a needle. Due to abrupt changes to diameter in the fluid flow path, solid particles may come out of suspension.
  • a drug delivery device including a reservoir for containing a medicament.
  • the medicament includes a suspension of solids in a liquid carrier.
  • the device also includes a needle having a distal end for injection into a patient, a proximal end in communication with the reservoir, and a lumen extending between the distal and proximal ends.
  • a path is defined from the reservoir to the distal end of the needle through the lumen, the path having an inner diameter that decreases in the proximal to distal direction along at least a portion thereof.
  • a flow path may be defined which provides a more gradual transition in diameter from the reservoir to the distal tip of a needle. In this manner, changes in velocity of the suspension may be less abrupt than in the prior art, thus better maintaining solid particles in the suspension.
  • FIG. 1 is a schematic of a drug delivery device formed in accordance with the subject invention in the form of a syringe;
  • FIG. 2 is a schematic of a drug delivery device formed in accordance with the subject invention in the form of a pen injector
  • FIGS. 3-9 show various configurations of an inlet fluid port usable with the subject invention.
  • a drug delivery device 10 is shown for delivery of a drug in a fluid suspension to an individual.
  • the drug delivery device 10 may be of various forms.
  • the drug delivery device 10 may be in the form of a syringe ( FIG. 1 ) or a pen injector or the like ( FIG. 2 ).
  • the drug delivery device 10 includes a reservoir 12 in which a suspension 14 is maintained.
  • the drug delivery device 10 includes a barrel 16 .
  • the barrel 16 includes a proximal end 18 and a distal end 20 .
  • proximal shall refer to the end of the component further away from the injection site (i.e., the “non-patient end”), while the term “distal” shall refer to the end toward the injection site (i.e., the “patient end”).
  • one or more stoppers 22 may be disposed in the barrel 16 in liquid-tight engagement therewith.
  • a plunger rod 24 extends from the stopper 22 in a proximal direction, e.g., so as to be accessible at the proximal end 18 of the barrel 16 .
  • the stopper 22 and the plunger rod 24 together form a plunger 26 which is usable for urging the suspension 14 from the reservoir 12 as described below.
  • An opening 28 ( FIG. 3 ) is defined in the distal end 20 of the barrel 16 which permits access to the reservoir 12 .
  • the opening 28 is sealed by a septum 30 , which is preferably made of an elastomeric material, as is well known in the art.
  • the barrel 16 may be formed with a reduced diameter adjacent to the distal end 20 so as to define a neck 32 onto which a pen needle assembly 34 may be mounted.
  • the pen needle assembly 34 includes a hub 36 to which is mounted a needle cannula 38 .
  • the hub 36 is formed to mount onto the barrel 16 , such as at the neck 32 , through the use of cooperating mounting members, such as threads, or may be affixed thereto (such as by adhesive or fusion).
  • the needle cannula 38 includes a proximal end 40 , formed to extend into the reservoir 12 with the hub 36 being mounted to the barrel 16 , and a distal end 42 , formed for insertion into a patient.
  • the needle cannula 38 extends through the septum 30 to access the reservoir 12 . With mounting the pen needle assembly 34 onto the barrel 16 , the needle cannula 38 pierces through the septum 30 .
  • a lumen 44 extends the length of the needle cannula 38 to communicate the proximal end 40 with the distal end 42 .
  • the reservoir 12 may be defined by a combination of various components, including the barrel 16 , the stopper 22 , and the septum 30 .
  • the pen needle assembly 34 being mounted to the barrel 16 , particularly with the proximal end 40 of the needle cannula 38 extending into the reservoir 12 , distal advancement of the plunger 26 will cause the suspension 14 to be urged through the needle cannula 38 .
  • the drug delivery device 10 is shown in the form of a pen injector.
  • a dose-setting mechanism schematically shown as a box 46 . Dose-setting mechanisms for pen injectors are well known in the prior art.
  • the plunger 26 is shown to be of the manually driven type. In both variations of FIGS. 1 and 2 , and in other possible configurations of the drug delivery device 10 , the plunger 26 may be configured to be manually, semi-automatically, or automatically driven.
  • a drug cartridge 48 is typically provided.
  • the drug cartridge 48 may include the barrel 16 , the stopper 22 and the septum 30 and define the reservoir 12 .
  • the main difference between the drug cartridge 48 and the configuration of FIG. 1 is that the pen needle assembly 34 is mounted to neck 50 defined on outer barrel 52 of the drug delivery device 10 , rather than being mounted to the barrel 16 .
  • the suspension 14 includes a medicament for delivery into an individual.
  • the suspension 14 includes solid components held in a liquid carrier.
  • the active medicament agent or agents may be in the solid components of the suspension 14 and/or in the liquid carrier.
  • the suspension 14 may contain solids dissolved to varying degrees, including at least some solids completely dissolved, or it may include solid particles, suspended in the liquid carrier.
  • the suspension 14 may be pre-mixed before it is disposed in the reservoir 12 , or it may be mixed after it has been disposed in the reservoir 12 .
  • the reservoir 12 may house a liquid diluent and a solid drug in separate compartments, such as in a reconstitution arrangement as is known in the art, where the two components are mixed prior to delivery to an individual. Examples of suitable reconstitution arrangements may be found, for example, in U.S. Pat. No. 4,874,381 and in U.S. Pat. No. 4,968,299, the contents of which are incorporated by reference herein.
  • a fluid inlet port 53 be provided which is in communication, and contiguous contact, with the suspension 14 in the reservoir 12 .
  • the fluid inlet port 53 defines a flow control surface 54 which includes a proximal end 56 and a distal end 58 , the proximal end 56 defining a larger diameter than the distal end 58 .
  • the proximal end 56 is located to be proximally of the proximal end 40 of the needle cannula 38 .
  • the proximal end 56 of the flow control surface 54 is configured to be larger than the lumen 44 of the needle cannula 38 , particularly at the proximal end 40 thereof.
  • the flow control surface 54 is generally tubular extending in a proximal to distal direction and formed with a converging shape going from the proximal end 56 to the distal end 58 .
  • the reduction in diameter may be gradual, such as being tapered, as shown in FIG. 3 , or formed with one or more step changes, as shown in FIG. 5 , or combinations thereof.
  • a flow path 60 for the suspension 14 is defined by at least the needle cannula 38 , particularly the lumen 44 , and the flow control surface 54 .
  • the flow path 60 is defined from the reservoir 12 to the distal end 42 of the needle cannula 38 .
  • the flow control surface 54 With the flow control surface 54 , at least a portion of the flow path 60 reduces in diameter as the suspension 14 flows in a distal direction.
  • the fluid path 60 is not defined by an immediate transition from the reservoir 12 to the needle cannula 38 , thereby avoiding a significant drop in diameter. Rather, the flow control surface 54 provides a more gradual change in diameter which better avoids abrupt velocity changes in the suspension 14 . With more gradual velocity changes, the suspension 14 may better maintain solid particles in solution.
  • the fluid inlet port 53 may be defined by the septum 30 .
  • a collar 62 may extend proximately from the septum 30 to define all or part of the fluid inlet port 53 .
  • the fluid inlet port 53 is defined within proximal face 64 of the septum 30 . More preferably, portions of the proximal face 64 surrounding the fluid inlet port 53 may be angularly disposed to convergently guide the suspension 14 towards the flow control surface 54 , as shown by the broken lines 66 .
  • Edge 68 defined at the junction of the flow control surface 54 and the proximal face 64 , may be rounded to further enhance the gradual change in velocity along the flow path 60 . It is preferred that all transitions (corners, edges, changes in diameter) along the fluid path 60 be rounded to define arcuate or radiused transitions. For example, with reference to FIG. 5 , edges 60 A, 60 B, and 60 C, in addition to the edge 60 , are preferably rounded.
  • the proximal end 40 of the needle cannula 38 coincide generally with the distal end 58 of the flow control surface 54 , with the pen needle assembly 34 being mounted to the device 10 .
  • the proximal end 40 may be configured to extend into the flow control surface 54 , proximally of the distal end 58 .
  • a channel 70 may extend distally from the distal end 58 .
  • the channel 70 may generally have the same diameter as the outer diameter of the needle cannula 38 .
  • the channel 70 may be configured such that the proximal end 40 is disposed therein during use. Flow then may pass from the flow control surface 54 to the needle cannula 38 , via the channel 70 . In this manner, the proximal end 40 of the needle cannula 38 is located distally of the distal end 58 of the fluid control surface 54 .
  • the needle cannula 38 may be directly fixed to the barrel 16 , such as in a staked needle configuration.
  • the inlet flow port 53 may be defined directly by the barrel 16 , particularly at the distal end 20 of the barrel 16 .
  • the distal end 20 of the barrel 16 may have a proximally-facing portion 72 located about the inlet flow port 53 .
  • the flow control surface 54 extends distally from the proximally-facing portion 72 .
  • the proximally-facing portion 72 may be tapered and/or arcuately formed, particularly to convergently direct the suspension 14 to the inlet flow port 53 .
  • the inlet flow port 53 and the flow control surface 54 may be defined as described above.
  • the suspension 14 is caused to be pressurized by the plunger 26 and urged distally. As the suspension 14 traverses the flow path 60 , the suspension 14 will be urged along an increasing smaller flow path, particularly across the flow control surface 54 . Even with the lumen 44 of the needle cannula 38 having a constant diameter, the flow control surface 54 allows for a gradual change in diameter. In this manner, a more gradual change in velocity is achieved, particularly in transitioning from the reservoir 12 to the proximal end 40 of the needle cannula 38 .
  • the lumen 44 of the needle cannula 38 with a change in diameter along the length thereof, particularly in a proximal to distal direction such that the lumen 44 at the proximal end 40 of the needle cannula 38 defines a larger diameter than at the distal end 42 of the needle cannula 38 .
  • the lumen 44 may be at least partially tapered in a proximal to distal direction. Other changes in diameter of the lumen 44 are possible.
  • the inlet flow port 53 may be defined by an ancillary or secondary component, such as by a sleeve 74 .
  • the hub 36 may include the sleeve 74 .
  • a proximal end 76 of the sleeve 74 be tapered or otherwise formed with a sharpened end such that with mounting of the hub 36 for use, the sleeve 74 may pierce through the septum 30 .
  • the inlet fluid port 53 may be defined by the sleeve 74 in similar fashion to that described above.
  • the sleeve 74 may be mounted to the needle cannula 38 with or without being mounted to the hub 36 .
  • the sleeve 74 may be provided as a separate component which is secured directly to the barrel 16 and the needle cannula 38 , such as in a staked needle configuration.
  • the barrel 16 may be configured as described above.
  • the various arrangements of the inlet fluid port 53 may be used in combination.
  • the fluid inlet port 53 may be defined in the septum 30 and the sleeve 74 (the sleeve 74 being mounted to the hub 36 and/or the needle cannula 38 ).
  • the flow control surfaces 54 both defined by the septum 30 and the sleeve 74 may collectively define the fluid path 60 so as to gradually reduce in diameter in a proximal to distal direction.
  • the proximal face 64 of the septum 30 may be angled and/or the lumen 44 of the needle cannula 38 may be tapered.
  • Various combinations of arrangements for generating reductions in the fluid path 60 may be utilized, particularly by the barrel 16 , the septum 30 , the sleeve 74 , and/or the lumen 44 , may be utilized.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
US12/863,474 2008-01-17 2009-01-20 Drug delivery device for drug suspensions Abandoned US20100292656A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/863,474 US20100292656A1 (en) 2008-01-17 2009-01-20 Drug delivery device for drug suspensions

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1140908P 2008-01-17 2008-01-17
US12/863,474 US20100292656A1 (en) 2008-01-17 2009-01-20 Drug delivery device for drug suspensions
PCT/US2009/031448 WO2009092084A1 (en) 2008-01-17 2009-01-20 Drug delivery device for drug suspensions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/031448 A-371-Of-International WO2009092084A1 (en) 2008-01-17 2009-01-20 Drug delivery device for drug suspensions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/455,767 Continuation US10463810B2 (en) 2008-01-17 2017-03-10 Drug delivery device for drug suspensions

Publications (1)

Publication Number Publication Date
US20100292656A1 true US20100292656A1 (en) 2010-11-18

Family

ID=40433793

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/863,474 Abandoned US20100292656A1 (en) 2008-01-17 2009-01-20 Drug delivery device for drug suspensions
US15/455,767 Active US10463810B2 (en) 2008-01-17 2017-03-10 Drug delivery device for drug suspensions
US16/593,332 Active 2029-10-23 US11547810B2 (en) 2008-01-17 2019-10-04 Drug delivery device for drug suspensions

Family Applications After (2)

Application Number Title Priority Date Filing Date
US15/455,767 Active US10463810B2 (en) 2008-01-17 2017-03-10 Drug delivery device for drug suspensions
US16/593,332 Active 2029-10-23 US11547810B2 (en) 2008-01-17 2019-10-04 Drug delivery device for drug suspensions

Country Status (5)

Country Link
US (3) US20100292656A1 (zh)
EP (1) EP2240223B1 (zh)
JP (1) JP5647006B2 (zh)
CN (2) CN101951981A (zh)
WO (1) WO2009092084A1 (zh)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130245559A1 (en) * 2012-03-16 2013-09-19 Becton, Dickinson And Company Drug delivery device for drug suspensions
US20140021076A1 (en) * 2011-03-25 2014-01-23 Terumo Kabushiki Kaisha Double-ended needle and mixing instrument
US20180169350A1 (en) * 2015-06-01 2018-06-21 Becton, Dickinson And Company Disposable pen needle with abbreviated non-patient end, and reusable pen interface
US20190060574A1 (en) * 2017-08-24 2019-02-28 Gerresheimer Regensburg Gmbh Adapter Element for Fastening a Needle Tip to a Syringe Base Body
WO2019157176A1 (en) * 2018-02-12 2019-08-15 Becton, Dickinson And Company Pen needle apparatus
US11090477B2 (en) * 2014-02-20 2021-08-17 Becton, Dickinson And Company IV access port cap for providing antimicrobial protection
US11419985B2 (en) * 2016-09-12 2022-08-23 Min Wei Medication injection device

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016163642A (ja) * 2015-03-06 2016-09-08 大成化工株式会社 針付きバレル及びこれを備えたシリンジ
US11154663B2 (en) * 2018-10-25 2021-10-26 Sharps Technology Inc. Pre-filled safety needle and syringe system
JP2023522300A (ja) * 2020-03-24 2023-05-30 ボストン サイエンティフィック サイムド，インコーポレイテッド 薬剤送達システム及びその使用方法
EP4019064A1 (en) * 2020-12-22 2022-06-29 Ypsomed AG Modular injection system

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2217602A (en) * 1938-05-12 1940-10-08 Macgregor Instr Company Hypodermic needle
US2646798A (en) * 1950-09-21 1953-07-28 Frank E Brown Cartridge syringe
US4553962A (en) * 1983-01-17 1985-11-19 Brunet Jean Louis Medical syringe
US6565550B1 (en) * 1999-05-10 2003-05-20 Carbon Medical Technologies, Inc. Luer fitting injector
US20040010235A1 (en) * 2002-07-11 2004-01-15 Weilbacher Eugene E. Anti-reflux syringe
US20040210196A1 (en) * 2001-07-27 2004-10-21 Bush Jr Charles L. Luer connector assembly
US6843783B2 (en) * 2000-09-14 2005-01-18 Terumo Kabushiki Kaisha Injection needle and injection apparatus

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1798142A (en) * 1924-01-30 1931-03-31 Cook Lab Inc Hypodermic syringe
US1715771A (en) * 1924-05-17 1929-06-04 Cook Lab Inc Hypodermic syringe and cartridge therefor
US2538391A (en) * 1948-01-10 1951-01-16 Arthur E Smith Syringe
DE3622399A1 (de) 1986-07-01 1988-02-04 Eberhardt Schlueter Selbsttaetige injektionsvorrichtung sowie ampulle oder patrone fuer eine injektionsvorrichtung
NL8802106A (nl) * 1988-08-26 1990-03-16 Abraham Van Den Haak Naaldbeveiliging voor een injectiespuit.
US5263934A (en) * 1991-11-28 1993-11-23 Haak Abraham Van Den Stroke limiting syringe with retractable needle
SE9201247D0 (sv) * 1992-04-21 1992-04-21 Kabi Pharmacia Ab Injection device
US6283949B1 (en) 1999-12-27 2001-09-04 Advanced Cardiovascular Systems, Inc. Refillable implantable drug delivery pump
JP2007283132A (ja) 2000-09-14 2007-11-01 Terumo Corp 液体注入針および液体注入装置
JP4083425B2 (ja) * 2001-01-25 2008-04-30 テルモ株式会社 液体注入針および液体注入装置
US6629962B2 (en) * 2001-04-17 2003-10-07 Machining Technologies, Inc. Needle design for live microorganisms
ES2660849T3 (es) * 2008-05-05 2018-03-26 Becton, Dickinson And Company Dispositivo de administración de medicamentos que tiene un cartucho con extremo distal agrandado

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2217602A (en) * 1938-05-12 1940-10-08 Macgregor Instr Company Hypodermic needle
US2646798A (en) * 1950-09-21 1953-07-28 Frank E Brown Cartridge syringe
US4553962A (en) * 1983-01-17 1985-11-19 Brunet Jean Louis Medical syringe
US6565550B1 (en) * 1999-05-10 2003-05-20 Carbon Medical Technologies, Inc. Luer fitting injector
US6843783B2 (en) * 2000-09-14 2005-01-18 Terumo Kabushiki Kaisha Injection needle and injection apparatus
US20040210196A1 (en) * 2001-07-27 2004-10-21 Bush Jr Charles L. Luer connector assembly
US20040010235A1 (en) * 2002-07-11 2004-01-15 Weilbacher Eugene E. Anti-reflux syringe

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140021076A1 (en) * 2011-03-25 2014-01-23 Terumo Kabushiki Kaisha Double-ended needle and mixing instrument
US20130245559A1 (en) * 2012-03-16 2013-09-19 Becton, Dickinson And Company Drug delivery device for drug suspensions
US10207053B2 (en) * 2012-03-16 2019-02-19 Becton, Dickinson And Company Drug delivery device for drug suspensions
US11452816B2 (en) 2012-03-16 2022-09-27 Becton, Dickinson And Company Drug delivery device for drug suspensions
US11752319B2 (en) 2014-02-20 2023-09-12 Becton, Dickinson And Company IV access port cap for providing antimicrobial protection
US11090477B2 (en) * 2014-02-20 2021-08-17 Becton, Dickinson And Company IV access port cap for providing antimicrobial protection
US10918807B2 (en) * 2015-06-01 2021-02-16 Becton, Dickinson And Company Disposable pen needle with abbreviated non-patient end, and reusable pen interface
US20180169350A1 (en) * 2015-06-01 2018-06-21 Becton, Dickinson And Company Disposable pen needle with abbreviated non-patient end, and reusable pen interface
US11419985B2 (en) * 2016-09-12 2022-08-23 Min Wei Medication injection device
US10946142B2 (en) * 2017-08-24 2021-03-16 Gerresheimer Regensburg Gmbh Adapter element for fastening a needle tip to a syringe base body
US20190060574A1 (en) * 2017-08-24 2019-02-28 Gerresheimer Regensburg Gmbh Adapter Element for Fastening a Needle Tip to a Syringe Base Body
WO2019157176A1 (en) * 2018-02-12 2019-08-15 Becton, Dickinson And Company Pen needle apparatus
US11684727B2 (en) 2018-02-12 2023-06-27 Embecta Corp. Pen needle apparatus

Also Published As

Publication number Publication date
CN106039485B (zh) 2019-09-03
US11547810B2 (en) 2023-01-10
EP2240223A1 (en) 2010-10-20
US20200030550A1 (en) 2020-01-30
JP5647006B2 (ja) 2014-12-24
WO2009092084A1 (en) 2009-07-23
EP2240223B1 (en) 2016-11-02
CN106039485A (zh) 2016-10-26
CN101951981A (zh) 2011-01-19
JP2011509765A (ja) 2011-03-31
US10463810B2 (en) 2019-11-05
US20170182262A1 (en) 2017-06-29

Similar Documents

Publication Publication Date Title
US11547810B2 (en) Drug delivery device for drug suspensions
JP5718338B2 (ja) キャップ機能を有する薬剤送達システムおよび装置
CN102413858B (zh) 用于传送药物溶液的笔式针头组件
US20160317389A1 (en) Seal System for Cannula
US7981089B2 (en) Vial access device
US11452816B2 (en) Drug delivery device for drug suspensions
CA2779206C (en) Syringe-carpule assembly
US20020065484A1 (en) Dual lumen subcutaneous injection set for use with a reservoir that has a septum
JP2017508588A (ja) キャップによって引き起こされる針の運動を有する薬剤送達装置
US20170340839A1 (en) Needle assembly for mixing of substances
JPS6137253A (ja) 通気された点滴瓶
CN110404136A (zh) 输送装置以及一种将胰岛素制剂引入给患者的方法
US2868201A (en) Aspirating needle hub
JP6360036B2 (ja) 薬瓶投薬システムおよび方法
US11071833B2 (en) Pen needle magazine
JPH026536B2 (zh)
JPH08117334A (ja) 混合用キット

Legal Events

Date Code Title Description
AS Assignment

Owner name: BECTON, DICKINSON AND COMPANY, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GROSKOPF, ROGER;MOTTAHED, BEHZAD D.;SIGNING DATES FROM 20100715 TO 20100719;REEL/FRAME:024703/0787

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION